Northern Trust’s GeneDx Holdings WGS Stock Holding History
Bought
Maintained
Sold
Other funds holding WGS
CM
CC
AIM
VCM
ZDA
Northern Trust's WGS Position: Q1 2026 in Review
Northern Trust reduced its GeneDx Holdings (WGS) stake by 12% in Q1 2026, selling an estimated $2.08M and leaving 175,767 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2002.
Northern Trust first reported a position in WGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $25.8M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.
- Northern Trust held 175,767 shares of GeneDx Holdings worth $11.3M as of Q1 2026.
- Northern Trust sold 22,854 GeneDx Holdings shares in Q1 2026, an estimated $2.08M.
- GeneDx Holdings made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2002 holding.
- Northern Trust first reported a position in GeneDx Holdings in Q3 2021 and has held it in 19 quarters since.
- Northern Trust's GeneDx Holdings position peaked at $25.8M in Q4 2025.
- 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.